Drug Clinical Trials List
Drug Clinical Trials List
| Study Title | Study Sponsor | Status | Study Drug | Trial Phase | Study Protocol Number | Site |
|---|---|---|---|---|---|---|
| An Open-label, Baseline-controlled, Multicenter, Phase 3 Dose-titration Study Followed by a Fixed-dose Observation Period to Evaluate Efficacy, Safety and Pharmacokinetics of Mirabegron in Children and Adolescents from 5 to less than 18 Years of Age with Neurogenic Detrusor Overactivity (NDO) on Clean Intermittent Catheterization (CIC) | Astellas | Rejected | Mirabegron | 3 | 178-CL-206A | King Abdulaziz University Hospital (Jeddah) |
| Vitamin D Status Correction and Validation of its Potential Clinical Utility through Discovery Proteomic Analysis | Prince Mutaib Chair for Biomarkers of Osteoporosis/synergypha-rma | Completed | cholecalciferol | 3 | E-15-1667 | KKUH |
| Vitamin D status and Covid-19 in Saudi Settings: A randomized open-label study on the possible role of vitamin D on improving clinical outcomes | KKUH | Ongoing | VITA-D | 3 | H-01-R-012 | King Fahad Medical City (Riyadh) |
| Vitamin C as a potential ameliorating agent against hepatotoxicity among alcoholic abusers | Qassim University | Completed | Vitamin C (ascorbic acid ) Cevital | 3 | 20111803 | Mental Health Hospital (Abha) |
| V212-001 A Phase III Randomized, Placebo-Controlled, Clinical Trial to Study the Safety and Efficacy of V212 in Adult Patients With Solid Tumor or Hematologic Malignancy | MSD | Completed | V212 | 3 | V212-011 | KFSH |
| Treatment of Neuroendocrine Tumors (NETs) with combination of Everolimus and Radiolabeld Somatostatin Analogue" | King Faisal Specialist Hospital and Research Centre | Ongoing | Everolimus | 2 | ONC-CRC 12- 12 or (RAC # 2121 159) | KFSH & RC-R |
| "Tranexamic acid for the treatment of significant traumatic brain injury: an international randomised, double blind placebo controlled trial" | London School of Hygiene & Tropical Medicine (LSHTM) | Ongoing | (Cyklokapron) Tranexamic Acid | 3 | ISRCTN15088122 | KSMC |
| "Tranexamic acid for the treatment of gastrointestinal hemorrhage: an international randomized, double-blind, placebo-controlled trial" | Prince Mohammad Bin Abdulaziz Hospital | Ongoing | Tranexamic acid | 3 | ISRCTN11225767 | PMBAH |
| Tocilizumab Efficacy and Safety in RA Patients After Inadequate Response to DMARDs or Anti-TNF | Roche | Completed | Tocilizumab | 3 | ML22726 | KFSH |
| THydroxychloroquine versus Standard of Care for the Management of COVID-19 | King Abdulaziz University Hospital | Completed | Hydroxychloroquine sulphate | 3 | 249-20 | KAUH-J |